BCL2 and clear cell renal carcinoma: (39) demonstrated that FOXO4 expression was decreased in clear cell renal carcinoma cells and that overexpression of FOXO4 significantly increased apoptosis rates and expression levels of BIM, BCL-2, BAX, and cytochrome c in clear cell renal carcinoma cells in vitro.